A phase II study of irinotecan, continuous 5-fluorouracil, and leucovorin (FOLFIRI) combination chemotherapy for patients with recurrent or metastatic gastric cancer previously treated with a fluoropyrimidine-based regimen.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples